This webinar examined how emerging technologies and scientific advances are transforming modern clinical embryology, bringing together internationally recognised experts to discuss innovations spanning chromosome segregation, laboratory traceability, and artificial intelligence.

Dr Eirini Bellou opened the session by presenting new approaches to preventing meiotic aneuploidy, exploring the biological mechanisms underlying chromosome segregation errors and discussing novel strategies aimed at improving oocyte quality and reducing aneuploid embryo formation.

Cynthia Hudson then focused on the critical role of witnessing and traceability within the IVF laboratory. Her presentation demonstrated how modern digital witnessing systems can strengthen patient safety, improve operational efficiency, and provide complete sample traceability throughout the assisted reproduction process.

The final presentation, delivered by Dr Matthew "Tex" VerMilyea together with Dr Tricia Adams, provided a practical roadmap for laboratories beginning their AI journey. The session explored the organisational, technical and cultural foundations required for successful AI implementation, highlighting the importance of data quality, workflow optimisation, staff engagement, and realistic expectations when introducing artificial intelligence into routine clinical practice.

The webinar concluded with an interactive panel discussion and live audience Q&A, during which the speakers addressed questions on implementing emerging technologies, maintaining laboratory quality and governance, and preparing IVF laboratories for the next generation of digital transformation.

Moderators:
Bill Venier & Dr Giovanni Coticchio

Presenters:
Dr Eirini Bellou, PhD: New Approaches to Prevent Meiotic Aneuploidy
Kindly sponsored by U-Ploid Biotechnologies

Cynthia Hudson: Total Recall
Kindly sponsored by Matcher & TMRW - proudly part of Reprotech

Dr Matthew “Tex” VerMilyea, PhD, HCLD/CC: 6 Clicks to Success: The Quick Start Guide to AI Readiness

with Dr Tricia Adams
Kindly sponsored by Alife Health

Q and A